Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

ALPHA 1 COMPLETES ACQUISITION

Dec. 24, 1991

SYNERGEN RECOMMENDATION REPEATED

Dec. 24, 1991

PHASE I TRIALS OF CANCER IMAGING AGENT

Dec. 24, 1991

SEPRACOR TO PRODUCE ANTI-HYPERTENSIVE

Dec. 24, 1991

COURT SMOTHERS NICODERM INJUNCTION

Dec. 23, 1991

FDA TO REVIEW CHIRON, CYTOGEN PRODUCTS

Dec. 23, 1991

CORVAS FILES FOR 2.5 MILLION-SHARE IPO

Dec. 23, 1991

IMMULOGIC FILES FOR 2 MILLION-SHARE OFFERING

Dec. 23, 1991

VIMRX FILES FOR OFFERING

Dec. 23, 1991

ONCOGENE RAISES $17.1 MILLION IN OFFERING

Dec. 23, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...